ARCHIVES

In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7%

This article is from The Cancer Letter archive.

Vol. 03 No. 04 | January 28, 1977

Download PDF Visit The Full Archive

Related Articles

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

In Brief: Cancer Program Bill Renews Congressional Commitment To Principles, Rep. Carter Says

May 5, 1978

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

ET2 Meber discusses Grants Funding Issue, Says Problem Is Money

July 23, 1993

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975